Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
Status: | Recruiting |
---|---|
Conditions: | Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 19 - Any |
Updated: | 4/2/2016 |
Start Date: | January 2014 |
A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination Compared to Laboratory Standard Procedures When Collected Through Peripheral Intravenous Catheters (PIVC)
This is a randomized, open label study to evaluate the Initial Specimen Diversion Device
(ISDD) in reducing the contamination rate in blood culture analysis. Blood culture data will
be derived from inpatient and/or outpatient settings in a variety of hospital departments
(e.g. ER, surgical, medical, etc.). Only samples that are collected via PIVC's may be
included in this study. The ISDD will be compared to current laboratory practices for the
collection of blood for culture purposes. Laboratory Standard Procedures (LSP) is defined as
collection of venipuncture blood for culture without an initial diversion method to divert
and sequester potential blood contaminants.
(ISDD) in reducing the contamination rate in blood culture analysis. Blood culture data will
be derived from inpatient and/or outpatient settings in a variety of hospital departments
(e.g. ER, surgical, medical, etc.). Only samples that are collected via PIVC's may be
included in this study. The ISDD will be compared to current laboratory practices for the
collection of blood for culture purposes. Laboratory Standard Procedures (LSP) is defined as
collection of venipuncture blood for culture without an initial diversion method to divert
and sequester potential blood contaminants.
Inclusion Criteria:
- Adults >19 years old
Exclusion Criteria:
- Not a good candidates for direct-to-media (DTM) technique
We found this trial at
1
site
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials